Parexel looks to Japan for eClinical growth

Parexel International ($PRXL) has inked a deal to pool its clinical trial data management service with a Japanese provider, teaming up to expand its share of the local market.

Under the deal, Parexel subsidiary Perceptive Informatics is collaborating with Japan's Fujitsu Systems West to seamlessly integrate their clinical trials software. Now, Perceptive's ClinPhone RTSM trial-monitoring program directly streams data into Fujitsu's DDworks 21, a regulatory compliance software, eliminating the need for manual entry and speeding up the development process, the company said.

"Clinical trial management is often hindered by complex, time-consuming manual processes for collecting, aggregating and rationalizing data," Perceptive Informatics Vice President Graham Bunn said in a statement. "Integrating our industry-leading technologies will replace fragmented methods for capturing and leveraging data. By streamlining these processes, clients can conduct clinical trials more efficiently."

The latest deal dovetails with Parexel's recent efforts to expand in Asia, especially with its eClinical business. Over the summer, Parexel cut the ribbon on a Shenyang, China, headquarters for Perceptive Informatics, aiming to increase adoption of its trial management offerings in the country. Late last year, Parexel launched a Perceptive Informatics customer care office in Shanghai, and the company has a similar operation up and running in Japan.

Last quarter, Parexel's Perceptive Informatics revenue grew 28.7% to $65.4 million, and the CRO giant is counting on a continued increase in demand for the rest of the year.

- read the announcement

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.